NIH-funded research NIH-funded research

Hepatitis B and HIV Cure Network to help people with HIV and hepatitis B

Official title: Hepatitis B and HIV Cure Consortium (BICC)

Funded at Johns Hopkins University · NIH-11423429 · Data updated 2026-11-12

A multinational effort to study why some people with HIV and chronic hepatitis B may eventually lose hepatitis B surface antigen and achieve a functional cure.

More Hepatitis B research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startSeptember 17, 2025
Project endJuly 31, 2030
Funding year2026
Award (this year)$170,735
NIH project number3U19AI188551-02S1
Project IDNIH-11423429 on NIH RePORTER

Who could benefit from this research

Could help

Adults living with HIV and chronic hepatitis B who can be followed long-term at participating international sites.

Less likely to help

People without HIV or chronic hepatitis B, or those unable to commit to long-term follow-up, may not benefit directly.

What this research studies

This project builds a large, international group of people living with HIV and chronic hepatitis B to study how a functional cure could be achieved. It uses advanced technologies and a shared clinical repository to analyze samples from diverse genotypes, with liver biopsies and blood draws to track changes over time. The goal is to identify factors linked to sustained HBsAg loss off treatment and to accelerate progress toward a cure that benefits people in the U.S. and around the world. Participation would involve regular follow-up visits and sample collection over several years at multiple sites. The research emphasizes collaboration, rigorous data sharing, and a patient-centered approach to translating findings into future care.

Why it matters

Potential benefit: If successful, this work could bring us closer to a functional cure for HBV in people with HIV, improving liver health and longevity.

How similar studies have gone: The study builds on existing HBV/HIV research using diverse international cohorts and biorepositories, with potential for new insights beyond prior work.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Thio, Chloe L — Johns Hopkins University
  • Study coordinator: Thio, Chloe L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.